Patent ID: 9345759
Filing Date: 2016-05-24
CPC Classification: A61K,A61P,C07K,C12N

Claim Text:
1. A composition comprising a BTV (Bluetongue Virus) VP2 antigen and a pharmaceutically or veterinarily acceptable carrier, excipient, adjuvant, or vehicles; wherein a nucleic acid sequence encoding the BTV VP2 antigen is expressed in a duckweed plant and said encoded antigen is localized to the cytoplasm of the duckweed plant; wherein said encoded antigen is non-glycosylated, and partially purified; wherein SEQ ID NO: 26 is fused immediately upstream of the nucleic acid sequence encoding the BTV VP2 antigen; and wherein the BTV VP2 antigen has at least 95% sequence identity to the sequence as set forth in SEQ ID NO: 4, and provides a protective immunogenic response in an animal against BTV infection.